- 2025.02.25
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated isosorbide dinitrate Tablet, uncoated 5 mg Anticipated Available Manufacturing 21/02/2025 ciprofloxacin hydrochloride Tablet, film coated 277.5 mg Anticipated Available Manufacturing 21/02/2025 ropinirole hydrochloride Tablet, film coated .57 mg Resolved Available Manufacturing 21/02/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 2 mg Resolved Available Unexpected increase in consumer demand 21/02/2025 risperidone Tablet, film coated 3 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 21/02/2025 letrozole Tablet, film coated 2.5 mg Anticipated Available Manufacturing 21/02/2025 levetiracetam Tablet, film coated 1000 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 21/02/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 21/02/2025 olanzapine Tablet, orally disintegrating 5 mg Current Limited Availability Manufacturing 21/02/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 21/02/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 21/02/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Unexpected increase in consumer demand 21/02/2025 sildenafil citrate Tablet, film coated 28.1 mg Anticipated Available Manufacturing 21/02/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 21/02/2025 quetiapine fumarate Tablet, modified release 460.52 mg Resolved Available Manufacturing 21/02/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 21/02/2025 metformin hydrochloride Tablet, modified release 1000 mg Discontinued Unavailable Commercial Changes / Commercial viability 21/02/2025 dutasteride Capsule, soft 500 microgram Anticipated Available Manufacturing 21/02/2025 linezolid Tablet, film coated 600 mg Anticipated Available Manufacturing 21/02/2025 ezetimibe Tablet 10 mg Resolved Available Manufacturing 21/02/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 21/02/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 3 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 21/02/2025 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 21/02/2025 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Current Unavailable Manufacturing 21/02/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 21/02/2025 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Anticipated Available Manufacturing 21/02/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Unexpected increase in consumer demand 21/02/2025 gramicidin~framycetin sulfate~dexamethasone Ear Drops .05 mg/mL~5 mg/mL~.5 mg/mL Anticipated Available Manufacturing 21/02/2025 estradiol~dydrogesterone Tablet, film coated 2 mg~10 mg Current Unavailable Manufacturing 21/02/2025 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Resolved Available Manufacturing 21/02/2025 flucloxacillin Injection, powder for 1 g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 21/02/2025 famotidine Tablet, film coated 20 mg Resolved Available Manufacturing 21/02/2025 mirtazapine Tablet, film coated 30 mg Anticipated Available Manufacturing 21/02/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 20/02/2025 amisulpride Tablet 100 mg Current Unavailable Manufacturing 20/02/2025 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/02/2025 mycophenolate mofetil Tablet, film coated 500 mg Current Unavailable Manufacturing 20/02/2025 mirtazapine Tablet, film coated 45 mg Current Unavailable Manufacturing 20/02/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Limited Availability Manufacturing 20/02/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 20/02/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Anticipated Available Manufacturing 20/02/2025 amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil Tablet 6.944 mg~25 mg~40 mg Current Limited Availability Manufacturing 20/02/2025 nicorandil Tablet 10 mg Current Limited Availability Manufacturing 20/02/2025 rizatriptan benzoate Wafer 14.53 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/02/2025 tobramycin Injection, solution 40 mg/mL Current Unavailable Unexpected increase in consumer demand 20/02/2025 esomeprazole Capsule, enteric 20 mg Resolved Available Manufacturing 20/02/2025 anastrozole Tablet, film coated 1 mg Current Unavailable Manufacturing 20/02/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 20/02/2025 mesalazine Tablet, enteric coated 250 mg Current Unavailable Manufacturing 20/02/2025 celecoxib Capsule, hard 100 mg Current Unavailable Manufacturing 20/02/2025 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Unexpected increase in consumer demand 20/02/2025 mefenamic acid Capsule, hard 250 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 20/02/2025 buprenorphine Patch, dermal 30 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/02/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 20/02/2025 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 4.8 mg~.78 mg~.512 mg Current Unavailable Manufacturing 20/02/2025 spironolactone Tablet, uncoated 25 mg Current Limited Availability Manufacturing 20/02/2025 sitagliptin fumarate Tablet, film coated 32.124 mg Current Unavailable Manufacturing 20/02/2025 alprazolam Tablet, uncoated 2 mg Anticipated Available Manufacturing 20/02/2025 Peginterferon alfa2a Injection, solution 135 microgram Anticipated Available Unexpected increase in consumer demand 20/02/2025 Peginterferon alfa2a Injection, solution 180 microgram Anticipated Available Unexpected increase in consumer demand 20/02/2025 citalopram hydrobromide Tablet, film coated 49.96 mg Current Limited Availability Manufacturing 20/02/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 20/02/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 20/02/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 20/02/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 19/02/2025 oxytocin Injection, solution 5 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/02/2025 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 19/02/2025 phenoxymethylpenicillin potassium Tablet, film coated 280 mg Resolved Available Manufacturing 19/02/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~25 mg Anticipated Available Manufacturing 19/02/2025 cinacalcet hydrochloride Tablet 99.191 mg Resolved Available Manufacturing 19/02/2025 potassium chloride Injection, concentrated 75 mg/mL Current Unavailable Commercial Changes / Commercial viability 19/02/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 19/02/2025 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Current Limited Availability Manufacturing 19/02/2025 oxaliplatin Injection, concentrated 100 mg Resolved Available Manufacturing 19/02/2025 nitrofurantoin Capsule, hard 100 mg Anticipated Available Manufacturing 19/02/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Current Limited Availability Manufacturing 19/02/2025 doxycycline hyclate Tablet, film coated 57.5 mg Resolved Available Manufacturing 19/02/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 19/02/2025 bupivacaine hydrochloride Injection, solution 5 mg/mL Resolved Available Manufacturing 18/02/2025 fluorouracil Injection, solution 5000 mg Current Unavailable Unexpected increase in consumer demand 18/02/2025 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 18/02/2025 amlodipine besilate Tablet 6.93 mg Resolved Available Manufacturing 18/02/2025 cisatracurium besilate Injection, solution 14.07 mg Resolved Available Transport / Logistic issues / Storage capacity issues 18/02/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 18/02/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 18/02/2025 ivabradine hydrochloride Tablet, film coated 8.085 mg Anticipated Available Manufacturing 18/02/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Anticipated Available Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 18/02/2025 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 6.95 mg~40 mg~12.5 mg Anticipated Available Manufacturing 18/02/2025 tenofovir disoproxil succinate~emtricitabine Tablet, film coated 300.6 mg~200 mg Current Unavailable Manufacturing 18/02/2025 mycophenolate sodium Tablet, enteric coated 384.7 mg Resolved Available Manufacturing 18/02/2025 lamotrigine Tablet, chewable 200 mg Current Limited Availability Unexpected increase in consumer demand 18/02/2025 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 18/02/2025 levothyroxine sodium Tablet, uncoated .2 mg Resolved Available Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 18/02/2025 norethisterone~ethinylestradiol Tablet, uncoated 500 microgram~36 microgram Current Limited Availability Unexpected increase in consumer demand 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/02/2025 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Current Unavailable Manufacturing 17/02/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 5 mg Current Limited Availability Unexpected increase in consumer demand 17/02/2025 metronidazole Tablet, uncoated 400 mg Anticipated Available Manufacturing 17/02/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 17/02/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 17/02/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 17/02/2025 bicalutamide Tablet, film coated 50 mg Current Unavailable Manufacturing 17/02/2025 quetiapine fumarate Tablet, modified release 172.695 mg Anticipated Available Unexpected increase in consumer demand 17/02/2025 quetiapine fumarate Tablet, film coated 28.78 mg Resolved Available Manufacturing 17/02/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 17/02/2025 escitalopram oxalate Tablet, film coated 25.47 mg Current Limited Availability Manufacturing 17/02/2025 clopidogrel besilate Tablet, film coated 112.1 mg Current Unavailable Manufacturing 17/02/2025 simvastatin Tablet, film coated 10 mg Resolved Available Manufacturing 17/02/2025 simvastatin Tablet, film coated 80 mg Current Unavailable Manufacturing 17/02/2025 morphine hydrochloride trihydrate Injection, solution 20 mg/mL Current Limited Availability Manufacturing 17/02/2025 tadalafil Tablet, film coated 20 mg Resolved Available Manufacturing 17/02/2025 ribociclib succinate Tablet, film coated 254.4 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/02/2025 lacosamide Tablet, film coated 100 mg Anticipated Available Unexpected increase in consumer demand 17/02/2025 pregabalin Capsule, hard 75 mg Resolved Available Unexpected increase in consumer demand 17/02/2025 famotidine Tablet, film coated 40 mg Current Unavailable Manufacturing 17/02/2025 - 2025.02.17
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated fentanyl Drug delivery system, transdermal 4.2 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/02/2025 morphine hydrochloride trihydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 14/02/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 22.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/02/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 7.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/02/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 22.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/02/2025 mupirocin Ointment 20 mg/g Current Limited Availability Unexpected increase in consumer demand 14/02/2025 ethanol absolute~carmustine Diluent, not applicable~Injection, powder for 3 mL~100 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/02/2025 tramadol hydrochloride Tablet, modified release 200 mg Resolved Available Manufacturing 13/02/2025 glyceryl trinitrate Injection, concentrated 50 mg Current Limited Availability Manufacturing 13/02/2025 levetiracetam Tablet, film coated 250 mg Resolved Available Manufacturing 13/02/2025 levodopa~entacapone~carbidopa monohydrate Tablet, film coated 125 mg~200 mg~33.75 mg Anticipated Available Manufacturing 13/02/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Anticipated Available Unexpected increase in consumer demand 13/02/2025 daptomycin Injection, powder for 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 13/02/2025 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 13/02/2025 heparin sodium Injection, solution 10 IU/mL Current Unavailable Manufacturing 13/02/2025 tobramycin Injection, solution 80 mg Resolved Available Manufacturing 12/02/2025 amlodipine besilate Tablet, uncoated 6.94 mg Resolved Available Manufacturing 12/02/2025 topiramate Tablet, film coated 200 mg Resolved Available Manufacturing 12/02/2025 letrozole Tablet, film coated 2.5 mg Current Unavailable Manufacturing 12/02/2025 vinblastine sulfate Injection, solution 1 mg/mL Current Limited Availability Manufacturing 12/02/2025 oxytocin Injection, solution 10 IU/mL Anticipated Available Manufacturing 12/02/2025 tadalafil Tablet, film coated 20 mg Resolved Available Manufacturing 12/02/2025 hydrochlorothiazide~olmesartan medoxomil Tablet 12.5 mg~20 mg Current Unavailable Manufacturing 12/02/2025 dosulepin (dothiepin) hydrochloride Tablet, film coated 75 mg Current Limited Availability Manufacturing 12/02/2025 Trastuzumab Injection, powder for 156 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 12/02/2025 mefenamic acid Capsule, hard 250 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 12/02/2025 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Unexpected increase in consumer demand 12/02/2025 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 12/02/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 12/02/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 12/02/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 12/02/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 12/02/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Unexpected increase in consumer demand 12/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 12/02/2025 balsalazide sodium Capsule 750 mg Anticipated Available Manufacturing 12/02/2025 nizatidine Capsule 150 mg Anticipated Available Manufacturing 12/02/2025 exemestane Tablet, film coated 25 mg Current Limited Availability Manufacturing 11/02/2025 acetylcysteine Injection, concentrated 2 g Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 11/02/2025 armodafinil Tablet, uncoated 50 mg Anticipated Available Manufacturing 11/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 11/02/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~10.341 mg Current Unavailable Manufacturing 11/02/2025 Bevacizumab Injection, concentrated 25 mg/mL Current Unavailable Commercial Changes / Commercial viability 11/02/2025 mupirocin calcium Cream 21.5 mg/g Current Limited Availability Manufacturing 11/02/2025 ioversol Injection, solution 509 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Unexpected increase in demand due to other sponsors unable to supply 11/02/2025 carboplatin Injection, solution 10 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/02/2025 ioversol Injection, solution 741 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 741 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 741 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~500 microgram Anticipated Available Unexpected increase in consumer demand 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 primidone Tablet, uncoated 250 mg Anticipated Available Manufacturing 10/02/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 2 mg Anticipated Available Unexpected increase in consumer demand 10/02/2025 neostigmine methylsulfate Injection, solution 2.5 mg Current Unavailable Manufacturing 10/02/2025 ribociclib succinate Tablet, film coated 254.4 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 10/02/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 10/02/2025 cisatracurium besilate Injection, solution 13.4 mg Anticipated Available Manufacturing 10/02/2025 pioglitazone hydrochloride Tablet, uncoated 16.53 mg Anticipated Available Commercial Changes / Commercial viability 10/02/2025 pioglitazone hydrochloride Tablet, uncoated 33.06 mg Anticipated Available Commercial Changes / Commercial viability 10/02/2025 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 10/02/2025 dinoprostone Gel .6667 mg/g Resolved Available Manufacturing 10/02/2025 - 2025.02.10
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated paclitaxel Injection, concentrated 6 mg/mL Resolved Available Manufacturing 7/02/2025 colistimethate sodium Injection, powder for IU Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/02/2025 olanzapine Tablet, orally disintegrating 20 mg Anticipated Available Manufacturing 7/02/2025 levetiracetam Tablet, film coated 250 mg Current Unavailable Manufacturing 7/02/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 7/02/2025 nicorandil Tablet 10 mg Anticipated Available Manufacturing 7/02/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Resolved Available Manufacturing 7/02/2025 fentanyl citrate Injection, solution 157 microgram Resolved Available Manufacturing 7/02/2025 fluorouracil Cream 50 mg/g Current Unavailable Manufacturing 7/02/2025 clindamycin phosphate Lotion 10 mg/mL Resolved Available Manufacturing 7/02/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~6.28 microgram/mL Discontinued Unavailable Commercial Changes / Commercial viability 7/02/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~6.28 microgram/mL Discontinued Unavailable Commercial Changes / Commercial viability 7/02/2025 citalopram hydrobromide Tablet, film coated 49.96 mg Anticipated Available Manufacturing 7/02/2025 carvedilol Tablet, film coated 6.25 mg Resolved Available Manufacturing 6/02/2025 ramipril Capsule, hard 1.25 mg Current Limited Availability Manufacturing 6/02/2025 octreotide Injection, solution 100 microgram Current Limited Availability Manufacturing 6/02/2025 octreotide Injection, solution 500 microgram Current Unavailable Manufacturing 6/02/2025 octreotide Injection, solution 50 microgram Current Limited Availability Manufacturing 6/02/2025 topiramate Tablet, film coated 200 mg Current Unavailable Manufacturing 6/02/2025 olanzapine Tablet, film coated 10 mg Current Limited Availability Manufacturing 6/02/2025 amisulpride Tablet 100 mg Current Limited Availability Manufacturing 6/02/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Anticipated Available Manufacturing 6/02/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 6/02/2025 trandolapril Capsule, hard .5 mg Resolved Available Manufacturing 6/02/2025 trandolapril Capsule, hard 1 mg Current Unavailable Manufacturing 6/02/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 6/02/2025 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 6/02/2025 risperidone Tablet, film coated 2 mg Current Unavailable Unexpected increase in consumer demand 6/02/2025 quetiapine fumarate Tablet, modified release 345.39 mg Anticipated Available Unexpected increase in consumer demand 6/02/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 6/02/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Unavailable Manufacturing 6/02/2025 esomeprazole Capsule, enteric 40 mg Current Unavailable Manufacturing 6/02/2025 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 6/02/2025 dosulepin (dothiepin) hydrochloride Tablet, film coated 75 mg Anticipated Available Manufacturing 6/02/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 6/02/2025 doxepin hydrochloride Capsule, hard 11.3 mg Current Limited Availability Manufacturing 6/02/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 6/02/2025 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Current Limited Availability Manufacturing 6/02/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Unexpected increase in consumer demand 6/02/2025 levothyroxine sodium Tablet, uncoated 50 microgram Current Unavailable Manufacturing 6/02/2025 metformin hydrochloride Tablet, film coated 850 mg Current Limited Availability Manufacturing 6/02/2025 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 6/02/2025 alprostadil Injection, powder for 40 microgram/mL Current Unavailable Manufacturing 6/02/2025 nizatidine Capsule 150 mg Anticipated Available Manufacturing 6/02/2025 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 5/02/2025 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Current Limited Availability Manufacturing 5/02/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 5/02/2025 sugammadex sodium Injection, solution 217.6 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/02/2025 acetylcysteine Injection, concentrated 2 g Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 5/02/2025 nicotinic acid Tablet, uncoated 250 mg Resolved Available Manufacturing 5/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 5/02/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 5/02/2025 melatonin Oral Liquid, solution 1 mg/mL Anticipated Available Unexpected increase in consumer demand 5/02/2025 carbidopa monohydrate~levodopa Tablet, uncoated 26.9 mg~100 mg Current Limited Availability Manufacturing 5/02/2025 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 5/02/2025 norethisterone~ethinylestradiol Tablet, uncoated 1 mg~36 microgram Current Limited Availability Manufacturing 5/02/2025 citalopram hydrobromide Tablet, film coated 24.98 mg Current Limited Availability Manufacturing 5/02/2025 nizatidine Capsule 300 mg Resolved Available Manufacturing 5/02/2025 sodium pertechnetate(99mTc) Injection, solution 18.5 GBq Current Unavailable Manufacturing 4/02/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Unavailable Transport / Logistic issues / Storage capacity issues 4/02/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 4/02/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 4/02/2025 mesalazine Tablet, enteric coated 800 mg Current Limited Availability Manufacturing 4/02/2025 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Limited Availability Manufacturing 4/02/2025 Influenza virus haemagglutinin Injection, suspension 15 microgram Current Unavailable Seasonal depletion of stock 4/02/2025 mefenamic acid Capsule, hard 250 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 4/02/2025 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Manufacturing 4/02/2025 Influenza virus haemagglutinin Injection, suspension 15 microgram Current Unavailable Seasonal depletion of stock 4/02/2025 albendazole Tablet, chewable 200 mg Resolved Available Manufacturing 4/02/2025 cisatracurium besilate Injection, solution 2.68 mg/mL Current Unavailable Manufacturing 4/02/2025 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Current Unavailable Manufacturing 4/02/2025 hydrocortisone acetate Eye Ointment 10 mg/g Resolved Available Manufacturing 3/02/2025 fentanyl Drug delivery system, transdermal 4.2 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/02/2025 tramadol hydrochloride Tablet, modified release 200 mg Resolved Available Manufacturing 3/02/2025 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/02/2025 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/02/2025 heparin sodium Injection, solution 25000 IU/mL Resolved Available Manufacturing 3/02/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.583 mg Current Unavailable Manufacturing 3/02/2025 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 10.396 mg~10 mg Current Limited Availability Manufacturing 3/02/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.791 mg Current Limited Availability Manufacturing 3/02/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Current Limited Availability Manufacturing 3/02/2025 midazolam Injection, solution 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 3/02/2025 eftrenonacog alfa Injection, powder for 250 IU Resolved Available Unexpected increase in consumer demand 3/02/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 43.4 mg~10 mg Resolved Available Manufacturing 3/02/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 86.8 mg~10 mg Current Unavailable Manufacturing 3/02/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/02/2025 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.935 mg Resolved Available Manufacturing 3/02/2025 nebivolol hydrochloride Tablet 1.363 mg Current Unavailable Manufacturing 3/02/2025 clobazam Tablet, uncoated 10 mg Current Unavailable Manufacturing 3/02/2025 dasatinib propylene glycol Tablet, film coated 58 mg Current Unavailable Manufacturing 3/02/2025 dasatinib propylene glycol Tablet, film coated 81.2 mg Current Unavailable Manufacturing 3/02/2025 dasatinib propylene glycol Tablet, film coated 116 mg Current Unavailable Manufacturing 3/02/2025 nitrofurantoin Capsule, hard 100 mg Anticipated Available Manufacturing 3/02/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Manufacturing 3/02/2025 carboplatin Injection, solution 10 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/02/2025 - 2025.02.03
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated Coxiella burnetii Injection 50 microgram/mL Resolved Available Manufacturing 31/01/2025 Coxiella burnetii Injection 5 microgram/mL Resolved Available Manufacturing 31/01/2025 carvedilol Tablet, film coated 6.25 mg Anticipated Available Manufacturing 31/01/2025 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/01/2025 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/01/2025 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/01/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Resolved Available Manufacturing 31/01/2025 fentanyl Drug delivery system, transdermal 8.4 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 31/01/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 31/01/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 31/01/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 31/01/2025 trandolapril Capsule, hard .5 mg Current Limited Availability Manufacturing 31/01/2025 quetiapine fumarate Tablet, modified release 172.695 mg Anticipated Available Unexpected increase in consumer demand 31/01/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 31/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 31/01/2025 metoprolol succinate Tablet, modified release 95 mg Current Limited Availability Manufacturing 31/01/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Unavailable Unexpected increase in consumer demand 31/01/2025 docetaxel Injection, concentrated 80 mg Resolved Available Manufacturing 31/01/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 31/01/2025 escitalopram oxalate Tablet, film coated 12.74 mg Resolved Available Transport / Logistic issues / Storage capacity issues 31/01/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 31/01/2025 buprenorphine Drug delivery system, transdermal 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 31/01/2025 azithromycin dihydrate Tablet, film coated 524 mg Resolved Available Manufacturing 31/01/2025 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Manufacturing 31/01/2025 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~12.5 mg Current Limited Availability Manufacturing 31/01/2025 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Current Unavailable Manufacturing 31/01/2025 tadalafil Tablet, film coated 20 mg Current Unavailable Manufacturing 31/01/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Current Limited Availability Manufacturing 31/01/2025 cisplatin Injection, concentrated 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 31/01/2025 pregabalin Capsule, hard 25 mg Current Unavailable Manufacturing 31/01/2025 olanzapine Tablet, uncoated 2.5 mg Resolved Available Manufacturing 31/01/2025 levothyroxine sodium Tablet, uncoated .05 mg Anticipated Available Unexpected increase in consumer demand 31/01/2025 gentamicin sulfate Injection, solution 135.6 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 31/01/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Current Limited Availability Manufacturing 31/01/2025 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~26.9 mg Current Limited Availability Manufacturing 31/01/2025 cabergoline Tablet, uncoated 1 mg Resolved Available Manufacturing 31/01/2025 midazolam Injection, solution 5 mg/mL Anticipated Available Unexpected increase in consumer demand 31/01/2025 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Manufacturing 31/01/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Current Limited Availability Manufacturing 31/01/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/01/2025 fludarabine phosphate Injection, concentrated 50 mg Resolved Available Manufacturing 30/01/2025 sodium fluoride Injection, concentrated 1 mg/mL Current Unavailable Manufacturing 30/01/2025 olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate Tablet 40 mg~25 mg~6.944 mg Current Limited Availability Manufacturing 30/01/2025 eftrenonacog alfa Injection, powder for 250 IU Current Unavailable Unexpected increase in consumer demand 30/01/2025 cyclopentolate hydrochloride Eye Drops, solution 10 mg/mL Resolved Available Manufacturing 30/01/2025 ropivacaine hydrochloride monohydrate Injection, solution 2.116 mg/mL Current Unavailable Commercial Changes / Commercial viability 30/01/2025 metformin hydrochloride Tablet, film coated 1000 mg Anticipated Available Manufacturing 30/01/2025 cisplatin Injection, concentrated 1 mg/mL Current Limited Availability Manufacturing 30/01/2025 encorafenib Capsule, hard 75 mg Resolved Available Manufacturing 30/01/2025 estradiol Drug delivery system, transdermal .39 mg Current Limited Availability Manufacturing 30/01/2025 estradiol hemihydrate Tablet, film coated 2.06 mg Anticipated Available Manufacturing 30/01/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Resolved Available Unexpected increase in consumer demand 30/01/2025 testosterone enantate Injection 250 mg/mL Resolved Available Unexpected increase in consumer demand 29/01/2025 clozapine Oral Liquid, suspension 50 mg/mL Current Unavailable Manufacturing 29/01/2025 pentetic acid Injection, powder for 5 mg Current Emergency Supply Only Manufacturing 29/01/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 29/01/2025 rizatriptan benzoate Wafer 14.53 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/01/2025 epirubicin hydrochloride Injection, concentrated 200 mg Current Unavailable Manufacturing 29/01/2025 Follitropin alfa Injection, solution 150 IU Anticipated Available Manufacturing 29/01/2025 benzatropine mesilate Injection 1 mg/mL Resolved Available Manufacturing 29/01/2025 clonazepam Tablet, uncoated .5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/01/2025 buprenorphine Patch, dermal 30 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/01/2025 oxaliplatin Injection, concentrated 100 mg Current Limited Availability Manufacturing 29/01/2025 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Resolved Available Unexpected increase in consumer demand 29/01/2025 tobramycin Injection, solution 80 mg Current Unavailable Manufacturing 28/01/2025 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 28/01/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 28/01/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 5 mg Current Limited Availability Unexpected increase in consumer demand 28/01/2025 omega3acid ethyl esters 90 Capsule, soft 1000 mg Anticipated Available Manufacturing 28/01/2025 oxytocin Injection, solution 10 IU Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/01/2025 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Resolved Available Manufacturing 28/01/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/01/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 28/01/2025 quetiapine fumarate Tablet, modified release 460.52 mg Current Limited Availability Manufacturing 28/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Resolved Available Manufacturing 28/01/2025 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/01/2025 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 28/01/2025 duloxetine hydrochloride Capsule, enteric 67.32 mg Resolved Available Commercial Changes / Commercial viability 28/01/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 28/01/2025 tranexamic acid Injection, solution 100 mg/mL Resolved Available Manufacturing 28/01/2025 cisatracurium besilate Injection, solution 14.07 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/01/2025 amiodarone hydrochloride Injection, solution 150 mg Anticipated Available Manufacturing 28/01/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 28/01/2025 mupirocin Ointment 20 mg/g Current Limited Availability Unexpected increase in consumer demand 28/01/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 28/01/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 28/01/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 28/01/2025 risperidone Tablet, film coated 3 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/01/2025 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 28/01/2025 pregabalin Capsule, hard 75 mg Current Unavailable Unexpected increase in consumer demand 28/01/2025 dimethyl fumarate Capsule, enteric 120 mg Current Limited Availability Manufacturing 28/01/2025 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 28/01/2025 levothyroxine sodium Tablet .05 mg Current Unavailable Manufacturing 28/01/2025 levothyroxine sodium Tablet .2 mg Current Unavailable Manufacturing 28/01/2025 levothyroxine sodium Tablet .1 mg Current Unavailable Manufacturing 28/01/2025 levothyroxine sodium Tablet .075 mg Current Unavailable Manufacturing 28/01/2025 olanzapine Tablet, uncoated 5 mg Anticipated Available Manufacturing 28/01/2025 - 2025.01.27
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 24/01/2025 amlodipine besilate Tablet, uncoated 6.94 mg Current Limited Availability Manufacturing 24/01/2025 ropinirole hydrochloride Tablet, film coated .57 mg Current Unavailable Manufacturing 24/01/2025 olanzapine Tablet, orally disintegrating 20 mg Resolved Available Manufacturing 24/01/2025 risperidone Tablet, film coated 3 mg Current Unavailable Manufacturing 24/01/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 24/01/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 24/01/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 24/01/2025 donepezil hydrochloride Tablet, film coated 10 mg Resolved Available Transport / Logistic issues / Storage capacity issues 24/01/2025 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/01/2025 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Anticipated Available Manufacturing 24/01/2025 hydrochlorothiazide~valsartan Tablet, film coated 12.5 mg~160 mg Anticipated Available Manufacturing 24/01/2025 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 24/01/2025 afatinib dimaleate Tablet, film coated 73.9 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/01/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Limited Availability Unexpected increase in consumer demand 24/01/2025 simvastatin Tablet, film coated 10 mg Current Limited Availability Manufacturing 24/01/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 24/01/2025 amiodarone hydrochloride Injection, solution 150 mg Anticipated Available 24/01/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 24/01/2025 tadalafil Tablet, film coated 10 mg Current Unavailable Manufacturing 24/01/2025 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 24/01/2025 solifenacin succinate Tablet, film coated 10 mg Current Unavailable Manufacturing 24/01/2025 pregabalin Capsule, hard 25 mg Current Limited Availability Manufacturing 24/01/2025 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 24/01/2025 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Unexpected increase in consumer demand 24/01/2025 adrenaline (epinephrine) Injection, solution 500 microgram Anticipated Available Manufacturing 24/01/2025 lamotrigine Tablet, chewable 100 mg Current Limited Availability Unexpected increase in consumer demand 24/01/2025 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Resolved Available Manufacturing 24/01/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 24/01/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/01/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/01/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/01/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/01/2025 levothyroxine sodium Tablet, uncoated .1 mg Current Unavailable Commercial Changes / Commercial viability 24/01/2025 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/01/2025 famotidine Tablet, film coated 20 mg Current Unavailable Manufacturing 24/01/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 24/01/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 24/01/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 24/01/2025 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 24/01/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 23/01/2025 topiramate Tablet, film coated 200 mg Current Limited Availability Manufacturing 23/01/2025 venlafaxine hydrochloride Capsule, modified release 169.71 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/01/2025 losartan potassium Tablet, film coated 50 mg Current Unavailable Manufacturing 23/01/2025 losartan potassium Tablet, film coated 25 mg Current Unavailable Manufacturing 23/01/2025 insulin Injection, solution 100 IU/mL Resolved Available Transport / Logistic issues / Storage capacity issues 23/01/2025 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 23/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Resolved Available Manufacturing 23/01/2025 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 23/01/2025 voriconazole Injection, powder for 200 mg Resolved Available Manufacturing 23/01/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/01/2025 celecoxib Capsule, hard 100 mg Current Limited Availability Manufacturing 23/01/2025 emtricitabine~tenofovir disoproxil succinate Tablet, film coated 200 mg~300.6 mg Current Unavailable Manufacturing 23/01/2025 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 23/01/2025 gemfibrozil Tablet, film coated 600 mg Current Unavailable Manufacturing 23/01/2025 doxycycline hyclate Tablet, film coated 57.5 mg Current Limited Availability Manufacturing 23/01/2025 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 23/01/2025 sugammadex sodium Injection, solution 544 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/01/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Limited Availability Transport / Logistic issues / Storage capacity issues 22/01/2025 phenoxymethylpenicillin potassium Tablet, film coated 280 mg Current Limited Availability Manufacturing 22/01/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, multilayer 10 mg~21.7 mg Current Limited Availability Manufacturing 22/01/2025 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 22/01/2025 nebivolol hydrochloride Tablet 10.9 mg Current Unavailable Manufacturing 22/01/2025 nebivolol hydrochloride Tablet 10.9 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/01/2025 levothyroxine sodium Tablet, uncoated .075 mg Current Unavailable Commercial Changes / Commercial viability 22/01/2025 levothyroxine sodium Tablet, uncoated .025 mg Current Unavailable Commercial Changes / Commercial viability 22/01/2025 levothyroxine sodium Tablet, uncoated .05 mg Current Unavailable Commercial Changes / Commercial viability 22/01/2025 levothyroxine sodium Tablet, uncoated .2 mg Current Unavailable Commercial Changes / Commercial viability 22/01/2025 isosorbide dinitrate Tablet, uncoated 5 mg Resolved Available Manufacturing 21/01/2025 hydrocortisone acetate Eye Ointment 10 mg/g Current Limited Availability Manufacturing 21/01/2025 acetylcysteine Injection, concentrated 2 g Resolved Available Transport / Logistic issues / Storage capacity issues 21/01/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Anticipated Available Manufacturing 21/01/2025 bisoprolol fumarate Tablet 10 mg Current Limited Availability Manufacturing 21/01/2025 eftrenonacog alfa Injection, powder for 250 IU Current Unavailable Unexpected increase in consumer demand 21/01/2025 desvenlafaxine Tablet, modified release 50 mg Resolved Available Manufacturing 21/01/2025 rosuvastatin calcium Tablet, film coated 41.68 mg Resolved Available Manufacturing 21/01/2025 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 21/01/2025 anastrozole Tablet, film coated 1 mg Current Unavailable Manufacturing 21/01/2025 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~12.5 mg Current Limited Availability Manufacturing 21/01/2025 bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 5.27 mg/mL~9.1 microgram/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 21/01/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 41.363 mg~10 mg Current Unavailable Manufacturing 21/01/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~20.681 mg Current Unavailable Manufacturing 21/01/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~82.725 mg Current Unavailable Manufacturing 21/01/2025 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Unavailable Manufacturing 21/01/2025 carboplatin Injection, solution 10 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 21/01/2025 azithromycin dihydrate Suspension, powder for 209.65 mg Resolved Available Unexpected increase in consumer demand 21/01/2025 ketamine hydrochloride Injection, solution 115.3 mg/mL Current Limited Availability Manufacturing 21/01/2025 pioglitazone hydrochloride Tablet, uncoated 33.06 mg Anticipated Available Manufacturing 21/01/2025 olanzapine Injection, powder for 10 mg Current Limited Availability Unexpected increase in consumer demand 21/01/2025 testosterone enantate Injection 250 mg/mL Anticipated Available Unexpected increase in consumer demand 20/01/2025 topiramate Tablet, film coated 50 mg Resolved Available Manufacturing 20/01/2025 zolpidem tartrate Tablet, film coated 10 mg Current Unavailable Manufacturing 20/01/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Limited Availability Manufacturing 20/01/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Anticipated Available Unexpected increase in consumer demand 20/01/2025 praziquantel Tablet, film coated 600 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 20/01/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Current Limited Availability Manufacturing 20/01/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 20/01/2025 rosuvastatin calcium Tablet, film coated 20.84 mg Resolved Available Manufacturing 20/01/2025 cabergoline Tablet, uncoated 1 mg Current Unavailable Manufacturing 20/01/2025 - 2025.01.20
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated Coxiella burnetii Injection 50 microgram/mL Current Unavailable Manufacturing 17/01/2025 clomipramine hydrochloride Tablet, film coated 25 mg Anticipated Available Manufacturing 17/01/2025 monobasic potassium phosphate Injection, concentrated 136.1 mg/mL Anticipated Available Manufacturing 17/01/2025 donepezil hydrochloride Tablet, film coated 10 mg Anticipated Available Manufacturing 17/01/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Anticipated Available Manufacturing 17/01/2025 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 17/01/2025 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 17/01/2025 bortezomib Injection, powder for 3.5 mg Current Limited Availability Manufacturing 17/01/2025 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 17/01/2025 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Resolved Available Manufacturing 17/01/2025 simvastatin Tablet, film coated 20 mg Resolved Available Manufacturing 17/01/2025 ibuprofen~codeine phosphate hemihydrate Tablet, film coated 200 mg~12.8 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/01/2025 esomeprazole Capsule, enteric 20 mg Current Limited Availability Manufacturing 17/01/2025 efavirenz~tenofovir disoproxil maleate~emtricitabine Tablet, film coated 600 mg~300 mg~200 mg Anticipated Available Manufacturing 17/01/2025 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 17/01/2025 Influenza virus haemagglutinin Injection, suspension 15 microgram Anticipated Available Seasonal depletion of stock 17/01/2025 celecoxib Capsule, hard 100 mg Anticipated Available Manufacturing 17/01/2025 Influenza virus haemagglutinin Injection, suspension 15 microgram Anticipated Available Seasonal depletion of stock 17/01/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 17/01/2025 atorvastatin calcium trihydrate Tablet, film coated 10.844 mg Anticipated Available Manufacturing 17/01/2025 atorvastatin calcium trihydrate Tablet, film coated 21.688 mg Anticipated Available Manufacturing 17/01/2025 spironolactone Tablet, uncoated 25 mg Anticipated Available Manufacturing 17/01/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Unexpected increase in consumer demand 17/01/2025 naproxen Tablet 500 mg Anticipated Available Manufacturing 17/01/2025 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/01/2025 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/01/2025 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~26.9 mg Anticipated Available Manufacturing 17/01/2025 pioglitazone hydrochloride Tablet, uncoated 16.53 mg Anticipated Available Manufacturing 17/01/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Resolved Available Transport / Logistic issues / Storage capacity issues 17/01/2025 famotidine Tablet, film coated 40 mg Current Limited Availability Manufacturing 17/01/2025 nizatidine Capsule 150 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 17/01/2025 nizatidine Capsule, hard 300 mg Resolved Available Manufacturing 17/01/2025 dinoprostone Gel .6667 mg/g Current Limited Availability Manufacturing 17/01/2025 sildenafil citrate Tablet, film coated 28.09 mg Resolved Available Unexpected increase in consumer demand 16/01/2025 adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate Injection, solution 22.7 microgram/mL~21.3 mg/mL Current Limited Availability Manufacturing 16/01/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 16/01/2025 ramipril Capsule, hard 1.25 mg Current Limited Availability Manufacturing 16/01/2025 topiramate Tablet, film coated 200 mg Current Limited Availability Manufacturing 16/01/2025 losartan potassium Tablet, film coated 50 mg Current Unavailable Manufacturing 16/01/2025 losartan potassium Tablet, film coated 25 mg Current Unavailable Manufacturing 16/01/2025 letrozole Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 16/01/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 16/01/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 16/01/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/01/2025 trandolapril Capsule, hard .5 mg Current Unavailable Manufacturing 16/01/2025 trandolapril Capsule, hard 1 mg Current Limited Availability Manufacturing 16/01/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 16/01/2025 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 16/01/2025 risperidone Tablet, film coated 1 mg Current Limited Availability Unexpected increase in consumer demand 16/01/2025 risperidone Tablet, film coated 2 mg Current Unavailable Unexpected increase in consumer demand 16/01/2025 phenoxymethylpenicillin potassium Tablet, film coated 280 mg Current Limited Availability Manufacturing 16/01/2025 metoprolol succinate Tablet, modified release 95 mg Anticipated Available Manufacturing 16/01/2025 metoprolol succinate Tablet, modified release 47.5 mg Current Unavailable Manufacturing 16/01/2025 metoprolol succinate Tablet, modified release 190 mg Current Unavailable Manufacturing 16/01/2025 amlodipine besilate Tablet 6.93 mg Current Unavailable Manufacturing 16/01/2025 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 16/01/2025 entecavir Tablet, film coated .5 mg Current Unavailable Manufacturing 16/01/2025 felypressin~prilocaine hydrochloride Injection, solution .54 microgram/mL~30 mg/mL Current Limited Availability Manufacturing 16/01/2025 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 16/01/2025 buprenorphine Drug delivery system, transdermal 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/01/2025 tenofovir disoproxil maleate Tablet, film coated 300 mg Current Limited Availability Manufacturing 16/01/2025 nicotinic acid Tablet, uncoated 250 mg Current Unavailable Manufacturing 16/01/2025 cefuroxime axetil Tablet, film coated 300.715 mg Resolved Available Manufacturing 16/01/2025 clonazepam Tablet, uncoated .5 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/01/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~25 mg Current Unavailable Manufacturing 16/01/2025 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Resolved Available Manufacturing 16/01/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 16/01/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 16/01/2025 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 16/01/2025 pegcetacoplan Injection, solution 1080 mg Resolved Available Manufacturing 16/01/2025 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 16/01/2025 furosemide Injection, solution 10 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 16/01/2025 metoprolol succinate Tablet, modified release 23.75 mg Resolved Available Manufacturing 16/01/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/01/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/01/2025 daptomycin Inhalation, powder for 350 mg Current Limited Availability Manufacturing 16/01/2025 rosuvastatin calcium~ezetimibe Tablet 10.4 mg~10 mg Resolved Available Manufacturing 16/01/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Resolved Available Manufacturing 16/01/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Anticipated Available Manufacturing 16/01/2025 fluticasone propionate Inhalation, conventional 1 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 16/01/2025 fluticasone propionate Inhalation, conventional .25 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 16/01/2025 fluticasone propionate Nasal Drops 400 microgram Discontinued Unavailable Commercial Changes / Commercial viability 16/01/2025 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 16/01/2025 pravastatin sodium Tablet, uncoated 40 mg Resolved Available Manufacturing 16/01/2025 clarithromycin Tablet, film coated 250 mg Resolved Available Unexpected increase in consumer demand 16/01/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Resolved Available Unexpected increase in consumer demand 15/01/2025 isosorbide dinitrate Tablet, uncoated 5 mg Anticipated Available Manufacturing 15/01/2025 fentanyl Drug delivery system, transdermal 8.4 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 15/01/2025 capecitabine Tablet, film coated 500 mg Current Unavailable Manufacturing 15/01/2025 tranexamic acid Injection, solution 100 mg/mL Current Unavailable Manufacturing 15/01/2025 fenofibrate Tablet 145 mg Current Limited Availability Manufacturing 15/01/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 15/01/2025 estradiol Drug delivery system, transdermal 1.56 mg Current Limited Availability Manufacturing 15/01/2025 trimethoprim Tablet, uncoated 300 mg Resolved Available Manufacturing 15/01/2025 omeprazole Tablet, enteric coated 20 mg Discontinued Unavailable Manufacturing 15/01/2025 prucalopride succinate Tablet 1.321 mg Current Unavailable Manufacturing 15/01/2025 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 15/01/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Unexpected increase in consumer demand 15/01/2025 prazosin hydrochloride Tablet, uncoated 1.095 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 14/01/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/01/2025 ropinirole hydrochloride Tablet, film coated .57 mg Current Unavailable Manufacturing 14/01/2025 fluorouracil Injection, solution 5000 mg Current Unavailable Unexpected increase in consumer demand 14/01/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Anticipated Available Manufacturing 14/01/2025 efmoroctocog alfa Injection, powder for 2000 IU Resolved Available Unexpected increase in consumer demand 14/01/2025 nebivolol hydrochloride Tablet 10.9 mg Current Limited Availability Manufacturing 14/01/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Limited Availability Manufacturing 14/01/2025 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 14/01/2025 solifenacin succinate Tablet, film coated 10 mg Current Unavailable Manufacturing 14/01/2025 aciclovir Injection, solution 25 mg/mL Current Limited Availability Manufacturing 14/01/2025 rosuvastatin calcium Tablet, film coated 20.84 mg Current Limited Availability Manufacturing 14/01/2025 flecainide acetate Tablet 50 mg Resolved Available Manufacturing 14/01/2025 levothyroxine sodium Tablet, uncoated .2 mg Current Limited Availability Manufacturing 14/01/2025 carbachol Injection, solution 100 microgram/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 14/01/2025 olanzapine Injection, powder for 10 mg Current Limited Availability Unexpected increase in consumer demand 14/01/2025 balsalazide sodium Capsule 750 mg Anticipated Available Manufacturing 14/01/2025 metformin hydrochloride Tablet, film coated 500 mg Anticipated Available Manufacturing 14/01/2025 oxytocin Injection, solution 10 IU Current Unavailable Manufacturing 13/01/2025 Choriogonadotropin alfa Injection, solution 250 microgram Current Limited Availability Unexpected increase in consumer demand 13/01/2025 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Unavailable Manufacturing 13/01/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 13/01/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Anticipated Available Manufacturing 13/01/2025 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 13/01/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Unexpected increase in consumer demand 13/01/2025 bicalutamide Tablet, film coated 50 mg Current Unavailable Manufacturing 13/01/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Limited Availability Unexpected increase in consumer demand 13/01/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 13/01/2025 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 13/01/2025 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/01/2025 Tocilizumab Injection, solution 162 mg Discontinued Unavailable Commercial Changes / Commercial viability 13/01/2025 rosuvastatin calcium Tablet, film coated 41.68 mg Anticipated Available Manufacturing 13/01/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 13/01/2025 acamprosate calcium Tablet, enteric coated 333 mg Current Limited Availability Manufacturing 13/01/2025 lacosamide Tablet, film coated 100 mg Anticipated Available Unexpected increase in consumer demand 13/01/2025 Tocilizumab Injection, solution 162 mg Discontinued Unavailable Commercial Changes / Commercial viability 13/01/2025 pregabalin Capsule, hard 75 mg Current Limited Availability Manufacturing 13/01/2025 olanzapine Tablet, uncoated 2.5 mg Current Unavailable Manufacturing 13/01/2025 lamotrigine Tablet, chewable 100 mg Current Limited Availability Unexpected increase in consumer demand 13/01/2025 - 2025.01.13
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated cytarabine Injection, solution 100 mg Resolved Available Unexpected increase in consumer demand 10/01/2025 topiramate Tablet, film coated 100 mg Resolved Available Manufacturing 10/01/2025 topiramate Tablet, film coated 200 mg Resolved Available Manufacturing 10/01/2025 levetiracetam Tablet, film coated 500 mg Resolved Available Manufacturing 10/01/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Unavailable Transport / Logistic issues / Storage capacity issues 10/01/2025 bisoprolol fumarate Tablet 2.5 mg Resolved Available Manufacturing 10/01/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 10/01/2025 eftrenonacog alfa Injection, powder for 1000 IU Resolved Available Unexpected increase in consumer demand 10/01/2025 eftrenonacog alfa Injection, powder for 250 IU Current Unavailable Unexpected increase in consumer demand 10/01/2025 clopidogrel besilate Tablet, film coated 112.1 mg Current Limited Availability Manufacturing 10/01/2025 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 10/01/2025 clonidine hydrochloride Tablet 100 microgram Current Unavailable Manufacturing 10/01/2025 irbesartan Tablet, film coated 300 mg Resolved Available Manufacturing 10/01/2025 ivabradine hydrochloride Tablet, film coated 8.085 mg Anticipated Available Manufacturing 10/01/2025 mesalazine Tablet, enteric coated 250 mg Current Limited Availability Manufacturing 10/01/2025 risperidone Tablet, film coated .5 mg Resolved Available Manufacturing 10/01/2025 ravulizumab Injection, intravenous infusion 100 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 10/01/2025 prucalopride succinate Tablet 2.642 mg Current Unavailable Manufacturing 10/01/2025 thiotepa Injection, powder for 15 mg Resolved Available Unexpected increase in consumer demand 10/01/2025 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 10/01/2025 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 10/01/2025 doxycycline hyclate Tablet, film coated 57.5 mg Current Limited Availability Manufacturing 10/01/2025 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 10/01/2025 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 10/01/2025 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 10/01/2025 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 10/01/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Current Unavailable Transport / Logistic issues / Storage capacity issues 10/01/2025 famotidine Tablet, film coated 20 mg Current Unavailable Manufacturing 10/01/2025 famotidine Tablet, film coated 40 mg Current Unavailable Manufacturing 10/01/2025 nizatidine Capsule, hard 300 mg Current Limited Availability Manufacturing 10/01/2025 dopamine hydrochloride Injection, concentrated 40 mg/mL Resolved Available Manufacturing 9/01/2025 paroxetine hydrochloride Tablet, film coated 22.21 mg Current Limited Availability Manufacturing 9/01/2025 mesalazine Tablet, enteric coated 800 mg Current Limited Availability Manufacturing 9/01/2025 Trastuzumab Injection, powder for 60 mg Current Unavailable Manufacturing 9/01/2025 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Manufacturing 9/01/2025 daptomycin Injection, powder for 500 mg Resolved Available Manufacturing 9/01/2025 Adalimumab Injection, solution 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 9/01/2025 carbamazepine Tablet, modified release 200 mg Resolved Available Manufacturing 9/01/2025 oxcarbazepine Tablet, film coated 150 mg Resolved Available Manufacturing 9/01/2025 citalopram hydrobromide Tablet, film coated 24.98 mg Current Limited Availability Manufacturing 9/01/2025 Meningococcal polysaccharide group C~Tetanus toxoid Injection, suspension 20 microgram/mL~20 microgram/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 9/01/2025 diclofenac sodium Suppository, moulded 50 mg Resolved Available Transport / Logistic issues / Storage capacity issues 9/01/2025 sevelamer hydrochloride Tablet, film coated 800 mg Resolved Available Manufacturing 8/01/2025 hydrocortisone acetate Eye Ointment 10 mg/g Current Unavailable Manufacturing 8/01/2025 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Resolved Available Manufacturing 8/01/2025 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 20.791 mg~10 mg Resolved Available Manufacturing 8/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Current Limited Availability Manufacturing 8/01/2025 efmoroctocog alfa Injection, powder for 2000 IU Current Unavailable Unexpected increase in consumer demand 8/01/2025 cisatracurium besilate Injection, solution 14.07 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 8/01/2025 citalopram hydrobromide Tablet, film coated 12.495 mg Current Unavailable Manufacturing 8/01/2025 buprenorphine Drug delivery system, transdermal 5 mg Current Limited Availability Manufacturing 8/01/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 8/01/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 20 mg~12.5 mg Current Unavailable Manufacturing 8/01/2025 hydrochlorothiazide~olmesartan medoxomil Tablet 25 mg~40 mg Current Limited Availability Manufacturing 8/01/2025 Trastuzumab Injection, powder for 150 mg Current Unavailable Manufacturing 8/01/2025 clobazam Tablet, uncoated 10 mg Current Unavailable Manufacturing 8/01/2025 oxaliplatin Injection, concentrated 100 mg Current Limited Availability Manufacturing 8/01/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Anticipated Available Manufacturing 8/01/2025 ethosuximide Capsule, soft 250 mg Discontinued Unavailable Manufacturing 8/01/2025 acetylcysteine Injection, concentrated 2 g Current Unavailable Manufacturing 7/01/2025 fentanyl Drug delivery system, transdermal 2.1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 7/01/2025 tramadol hydrochloride Tablet, modified release 200 mg Current Limited Availability Manufacturing 7/01/2025 bisoprolol fumarate Tablet 5 mg Resolved Available Manufacturing 7/01/2025 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 7/01/2025 bortezomib Injection, powder for 3.5 mg Current Limited Availability Manufacturing 7/01/2025 amlodipine besilate Tablet 6.93 mg Current Limited Availability Manufacturing 7/01/2025 doxylamine succinate~codeine phosphate hemihydrate~paracetamol Tablet, uncoated 5.1 mg~10 mg~500 mg Resolved Available Manufacturing 7/01/2025 cefuroxime axetil Tablet, film coated 300.715 mg Current Limited Availability Manufacturing 7/01/2025 ezetimibe Tablet 10 mg Resolved Available Unexpected increase in consumer demand 7/01/2025 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 7/01/2025 tadalafil Tablet, film coated 20 mg Resolved Available Manufacturing 7/01/2025 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~40 mg Current Unavailable Manufacturing 7/01/2025 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Resolved Available Manufacturing 7/01/2025 dimethyl fumarate Capsule, enteric 120 mg Current Limited Availability Manufacturing 7/01/2025 metoprolol succinate Tablet, modified release 23.75 mg Current Limited Availability Manufacturing 7/01/2025 lanreotide acetate Injection, solution 133.33 mg Resolved Available Transport / Logistic issues / Storage capacity issues 7/01/2025 lanreotide acetate Injection, solution 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 7/01/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 7/01/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 7/01/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 7/01/2025 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 7/01/2025 heparin sodium Injection, solution 5000 IU/mL Resolved Available Manufacturing 7/01/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Resolved Available Manufacturing 7/01/2025 gabapentin Tablet, film coated 800 mg Current Unavailable Manufacturing 6/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Resolved Available Manufacturing 6/01/2025 quetiapine fumarate Tablet, film coated 345.36 mg Resolved Available Manufacturing 6/01/2025 adefovir dipivoxil Tablet 10 mg Resolved Available Unexpected increase in consumer demand 6/01/2025 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 6/01/2025 apomorphine hydrochloride hemihydrate Injection, solution 10 mg Resolved Available Manufacturing 6/01/2025 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 6/01/2025 furosemide Injection, solution 10 mg/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 6/01/2025 rosuvastatin calcium~ezetimibe Tablet 10.4 mg~10 mg Current Unavailable Manufacturing 6/01/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Current Unavailable Manufacturing 6/01/2025 tamoxifen citrate Tablet, uncoated 30.4 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/01/2025 cabergoline Tablet, uncoated 1 mg Anticipated Available Manufacturing 6/01/2025 - 2025.01.06
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated paclitaxel Injection, concentrated 6 mg/mL Current Limited Availability Manufacturing 3/01/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Anticipated Available Manufacturing 3/01/2025 galantamine hydrobromide Capsule, modified release 30.756 mg Current Limited Availability Manufacturing 3/01/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 3/01/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Limited Availability Manufacturing 3/01/2025 buprenorphine Drug delivery system, transdermal 5 mg Current Limited Availability Manufacturing 3/01/2025 linezolid Tablet, film coated 600 mg Anticipated Available Manufacturing 3/01/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Limited Availability Manufacturing 3/01/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 3/01/2025 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 3/01/2025 potassium chloride Injection, concentrated 75 mg/mL Current Unavailable Commercial Changes / Commercial viability 3/01/2025 mesalazine Tablet, enteric coated 1.6 g Current Limited Availability Manufacturing 3/01/2025 Fremanezumab Injection, solution 225 mg Resolved Available Unexpected increase in consumer demand 3/01/2025 sitagliptin fumarate Tablet, film coated 32.124 mg Current Unavailable Manufacturing 3/01/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Unexpected increase in consumer demand 3/01/2025 rifabutin Capsule, hard 150 mg Resolved Available Transport / Logistic issues / Storage capacity issues 3/01/2025 aciclovir Injection, solution 25 mg/mL Resolved Available Manufacturing 3/01/2025 azithromycin dihydrate Tablet, film coated 628.93 mg Resolved Available Manufacturing 3/01/2025 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Current Limited Availability Unexpected increase in consumer demand 3/01/2025 estradiol~dydrogesterone Tablet, film coated 2 mg~10 mg Anticipated Available Manufacturing 3/01/2025 pioglitazone hydrochloride Tablet, uncoated 33.06 mg Anticipated Available Manufacturing 3/01/2025 morphine sulfate pentahydrate Tablet, modified release 10 mg Current Unavailable Manufacturing 2/01/2025 morphine sulfate pentahydrate Tablet, modified release 30 mg Current Unavailable Manufacturing 2/01/2025 morphine sulfate pentahydrate Tablet, modified release 60 mg Current Unavailable Manufacturing 2/01/2025 morphine sulfate pentahydrate Tablet, modified release 100 mg Current Unavailable Manufacturing 2/01/2025 venlafaxine Capsule, modified release 75 mg Resolved Available Manufacturing 2/01/2025 venlafaxine Capsule, modified release 150 mg Resolved Available Manufacturing 2/01/2025 metronidazole Tablet, uncoated 400 mg Anticipated Available Manufacturing 2/01/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 2/01/2025 morphine hydrochloride trihydrate Injection, solution 10 mg/mL Current Limited Availability Manufacturing 2/01/2025 pemetrexed disodium Injection, powder for 110.28 mg Current Unavailable Manufacturing 2/01/2025 pemetrexed disodium Injection, powder for 551.4 mg Current Limited Availability Manufacturing 2/01/2025 pemetrexed disodium Injection, powder for 1102.8 mg Current Unavailable Manufacturing 2/01/2025 betahistine dihydrochloride Tablet 24 mg Resolved Available Unexpected increase in consumer demand 2/01/2025 nebivolol hydrochloride Tablet 10.9 mg Anticipated Available Manufacturing 2/01/2025 ropinirole hydrochloride Tablet, film coated .285 mg Resolved Available Manufacturing 2/01/2025 risperidone Tablet, film coated .5 mg Anticipated Available Manufacturing 2/01/2025 levothyroxine sodium Tablet .05 mg Current Unavailable Manufacturing 2/01/2025 levothyroxine sodium Tablet .2 mg Current Limited Availability Manufacturing 2/01/2025 levothyroxine sodium Tablet .1 mg Current Unavailable Manufacturing 2/01/2025 fentanyl citrate Injection, solution 157 microgram Current Unavailable Manufacturing 2/01/2025 levothyroxine sodium Tablet 50 microgram Resolved Available Manufacturing 2/01/2025 melatonin Capsule, hard 5 mg Resolved Available Unexpected increase in consumer demand 2/01/2025 melatonin Oral Liquid, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 2/01/2025 riboflavine sodium phosphate~folic acid~sodium pantothenate~Biotin~pyridoxine hydrochloride~cyanocobalamin~sodium ascorbate~nicotinamide~thiamine nitrate Injection, powder for 4.9 mg~.4 mg~16.5 mg~60 microgram~4.9 mg~5 microgram~113 mg~40 mg~3.1 mg Resolved Available Manufacturing 2/01/2025 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 2/01/2025 - 2024.12.30
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated Choriogonadotropin alfa Injection, solution 250 microgram Current Emergency Supply Only Unexpected increase in consumer demand 24/12/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 toremifene citrate Tablet, uncoated 88.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 prazosin hydrochloride Tablet, uncoated 1.095 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/12/2024 morphine hydrochloride trihydrate Oral Liquid, solution 10 mg/mL Current Unavailable Commercial Changes / Commercial viability 23/12/2024 fentanyl Drug delivery system, transdermal 2.1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 23/12/2024 insulin Injection, solution 100 IU/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 23/12/2024 Somatropin Injection, solution 3.33 mg/mL Resolved Available Manufacturing 23/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 23/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Current Limited Availability Manufacturing 23/12/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Resolved Available Manufacturing 23/12/2024 mesalazine Tablet, enteric coated 800 mg Anticipated Available Manufacturing 23/12/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~13.88 mg Resolved Available Manufacturing 23/12/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.94 mg Resolved Available Unexpected increase in consumer demand 23/12/2024 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.94 mg~20 mg Resolved Available Manufacturing 23/12/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 23/12/2024 ezetimibe Tablet 10 mg Resolved Available Manufacturing 23/12/2024 - 2024.12.23
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated cytarabine Injection, solution 100 mg Current Limited Availability Unexpected increase in consumer demand 20/12/2024 topiramate Tablet, film coated 25 mg Resolved Available Manufacturing 20/12/2024 topiramate Tablet, film coated 100 mg Current Unavailable Manufacturing 20/12/2024 topiramate Tablet, film coated 200 mg Current Unavailable Manufacturing 20/12/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Unexpected increase in consumer demand 20/12/2024 fentanyl Drug delivery system, transdermal 16.8 mg Current Limited Availability Manufacturing 20/12/2024 olanzapine Tablet, orally disintegrating 20 mg Current Limited Availability Manufacturing 20/12/2024 levetiracetam Tablet, film coated 250 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/12/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Limited Availability Manufacturing 20/12/2024 trandolapril Capsule, hard 1 mg Current Limited Availability Manufacturing 20/12/2024 olmesartan medoxomil Tablet, film coated 40 mg Current Unavailable Manufacturing 20/12/2024 simvastatin Tablet, film coated 40 mg Resolved Available Manufacturing 20/12/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 20/12/2024 voriconazole Injection, powder for 200 mg Current Unavailable Manufacturing 20/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 20/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 20/12/2024 dasatinib Tablet, film coated 20 mg Anticipated Available Unexpected increase in consumer demand 20/12/2024 fenofibrate Tablet 145 mg Anticipated Available Manufacturing 20/12/2024 teriflunomide Tablet, film coated 14 mg Current Unavailable Manufacturing 20/12/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Current Unavailable Manufacturing 20/12/2024 hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate Tablet, film coated 25 mg~40 mg~6.95 mg Resolved Available Manufacturing 20/12/2024 gentamicin sulfate Injection, solution 135.6 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/12/2024 sodium amidotrizoate~amidotrizoate meglumine Injection, solution 40 mg/mL~260 mg/mL Current Unavailable Manufacturing 20/12/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 20/12/2024 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 20/12/2024 methylphenidate hydrochloride Capsule, modified release 40 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 19/12/2024 tazobactam sodium~piperacillin sodium Injection, powder for .54 g~4.2 g Discontinued Unavailable Unexpected increase in consumer demand 19/12/2024 fentanyl Drug delivery system, transdermal 12.6 mg Anticipated Available Manufacturing 19/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 19/12/2024 diazepam Tablet, uncoated 2 mg Resolved Available Manufacturing 19/12/2024 azithromycin Injection, powder for 500 mg Current Unavailable Commercial Changes / Commercial viability 19/12/2024 trandolapril Capsule, hard .5 mg Current Unavailable Manufacturing 19/12/2024 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 19/12/2024 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 19/12/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 19/12/2024 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 19/12/2024 emtricitabine~tenofovir disoproxil maleate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 19/12/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 19/12/2024 lorazepam Tablet 2.5 mg Resolved Available Manufacturing 19/12/2024 tenofovir disoproxil succinate~emtricitabine Tablet, film coated 300.6 mg~200 mg Current Unavailable Manufacturing 19/12/2024 rosuvastatin calcium Tablet, film coated 20.84 mg Current Limited Availability Manufacturing 19/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 19/12/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Resolved Available Unexpected increase in consumer demand 19/12/2024 dostarlimab Injection, intravenous infusion 500 mg/mL Resolved Available Unexpected increase in consumer demand 19/12/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/12/2024 citalopram hydrobromide Tablet, film coated 24.98 mg Anticipated Available Manufacturing 19/12/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 19/12/2024 clarithromycin Tablet, film coated 250 mg Current Unavailable Unexpected increase in consumer demand 19/12/2024 moclobemide Tablet, film coated 150 mg Resolved Available Manufacturing 19/12/2024 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Unexpected increase in consumer demand 18/12/2024 sildenafil citrate Tablet, film coated 28.09 mg Current Unavailable Unexpected increase in consumer demand 18/12/2024 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 18/12/2024 tranexamic acid Injection, solution 1000 mg Anticipated Available Manufacturing 18/12/2024 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 18/12/2024 efmoroctocog alfa Injection, powder for 250 IU Resolved Available Unexpected increase in consumer demand 18/12/2024 paroxetine hydrochloride Tablet, film coated 22.21 mg Anticipated Available Manufacturing 18/12/2024 buprenorphine Drug delivery system, transdermal 5 mg Current Limited Availability Manufacturing 18/12/2024 mesalazine Tablet, enteric coated 800 mg Anticipated Available Manufacturing 18/12/2024 mesalazine Tablet, enteric coated 1.6 g Anticipated Available Manufacturing 18/12/2024 Fremanezumab Injection, solution 225 mg Current Limited Availability Unexpected increase in consumer demand 18/12/2024 clonazepam Tablet, uncoated .5 mg Resolved Available Manufacturing 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 18/12/2024 terbinafine hydrochloride Tablet, uncoated 281.3 mg Resolved Available Manufacturing 17/12/2024 isosorbide dinitrate Tablet, uncoated 5 mg Resolved Available Manufacturing 17/12/2024 fluorouracil Injection, solution 5000 mg Anticipated Available Unexpected increase in consumer demand 17/12/2024 acetylcysteine Injection, concentrated 2 g Current Unavailable Transport / Logistic issues / Storage capacity issues 17/12/2024 olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide Tablet 40 mg~6.944 mg~25 mg Current Limited Availability Manufacturing 17/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/12/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 17/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Limited Availability Manufacturing 17/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Anticipated Available Manufacturing 17/12/2024 temozolomide Capsule, hard 5 mg Resolved Available Manufacturing 17/12/2024 temozolomide Capsule, hard 20 mg Resolved Available Manufacturing 17/12/2024 temozolomide Capsule, hard 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/12/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Resolved Available Manufacturing 17/12/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Limited Availability Manufacturing 17/12/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 17/12/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 17/12/2024 gemeprost Pessary 1 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 17/12/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Anticipated Available Manufacturing 17/12/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 17/12/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Resolved Available Manufacturing 17/12/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Current Unavailable Commercial Changes / Commercial viability 17/12/2024 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 17/12/2024 pregabalin Capsule, hard 25 mg Current Limited Availability Manufacturing 17/12/2024 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 17/12/2024 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 17/12/2024 olanzapine Tablet, uncoated 2.5 mg Current Unavailable Manufacturing 17/12/2024 methotrexate Tablet 2.5 mg Anticipated Available Manufacturing 17/12/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Current Unavailable Manufacturing 17/12/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Current Unavailable Manufacturing 17/12/2024 clindamycin phosphate Lotion 10 mg/mL Current Unavailable Manufacturing 17/12/2024 famotidine Tablet, film coated 20 mg Current Unavailable Manufacturing 17/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 17/12/2024 risperidone Tablet, film coated 2 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2024 carboplatin Injection, solution 450 mg Current Limited Availability Manufacturing 16/12/2024 bosentan monohydrate Tablet, film coated 129.08 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/12/2024 mesalazine Tablet, enteric coated 250 mg Anticipated Available Manufacturing 16/12/2024 rasagiline mesilate Tablet 1.56 mg Resolved Available Manufacturing 16/12/2024 lacosamide Tablet, film coated 150 mg Resolved Available Transport / Logistic issues / Storage capacity issues 16/12/2024 isavuconazonium sulfate Capsule 186.3 mg Resolved Available Unexpected increase in consumer demand 16/12/2024 furosemide Injection, solution 10 mg/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/12/2024 thiotepa Injection, powder for 15 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 16/12/2024 nizatidine Capsule 150 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 16/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 16/12/2024